Receptor binding

Definition

Receptor binding is the process by which a ligand (a small molecule, peptide, or protein) attaches to a specific receptor protein on or in a cell. Receptors are proteins with defined three-dimensional structures that recognize and bind specific ligands with high specificity and affinity. The binding interaction is typically described using the lock-and-key model, where the ligand (key) fits into the binding pocket (lock) of the receptor. Receptor binding is usually reversible; the ligand and receptor associate and dissociate in equilibrium. The affinity of a ligand for a receptor is quantified by the dissociation constant (Kd), which describes the concentration of ligand required to occupy half of the receptors in a system. Lower Kd values indicate higher affinity (tighter binding). Once bound, a ligand can either activate the receptor (act as an agonist) or occupy the binding site without activating it (act as an antagonist). In research, receptor-binding assays measure the affinity and selectivity of peptides or other compounds for target receptors, informing the design of more selective and potent therapeutic candidates.

The specificity of receptor binding arises from the precise shape and chemical properties of the receptor's binding pocket. The ligand must fit into the pocket with complementary geometry and form favorable interactions (hydrogen bonds, electrostatic interactions, hydrophobic interactions) with amino acid residues in the binding site. This specificity allows cells to respond selectively to one hormone or signaling molecule among thousands present in body fluids. Therapeutic peptides are often engineered to optimize receptor binding affinity and selectivity; structural modifications such as amino acid substitutions, cyclization, or conjugation to other molecules can increase affinity or improve selectivity for the target receptor while reducing off-target binding.

Understanding receptor binding kinetics (the rate at which ligands bind and unbind from receptors) is also important. A compound with fast on-rate and slow off-rate produces a long duration of action, while a compound with fast off-rate produces a shorter duration. These kinetic properties, combined with pharmacokinetic properties (half-life, clearance), determine the overall duration of drug action in the body. Researchers use biophysical techniques such as surface plasmon resonance and fluorescence polarization to measure binding kinetics and characterize receptor interactions quantitatively.